Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landenniveau. Duik in de details door op de stippen te klikken.
Onderzoeksoutput
-
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe
Koomen, J. V., Stevens, J., Monster-Simons, M. H., Heerspink, H. J. L. & Mol, P. G. M., 28-apr-2021, In: Frontiers in Pharmacology. 12, 11 blz.Onderzoeksoutput › peer review
Open AccessBestand -
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders
Jonker, C. J., de Vries, S., van den Berg, H. M., McGettigan, P., Hoes, A. W. & Mol, P. G. M., 6-jun-2021, In: Drug Safety. 9 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand -
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
Roldan Munoz, S., Postmus, D., de Vries, S. T., Arnardottir, A. H., Dolu, İ., Hillege, H. & Mol, P. G. M., feb-2021, In: Frontiers in Pharmacology. 11, 6 blz., 617409.Onderzoeksoutput › Academic › peer review
Open AccessBestand -
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
Bakker, E., Mol, P. G. M., Nabais, J., Vetter, T., Kretzler, M., Nolan, J. J., Mayer, G., Sundgren, A., Heerspink, H., Schiel, A., de Vries, S., Gomez, M. F., Schulze, F., de Zeeuw, D. & Pena, M., 4-mei-2021, In: Frontiers in Pharmacology. 12, 662642.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Downloads (Pure) -
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
Dekker, M. J. H. J., de Vries, S., Versantvoort, C. H., Drost-van Velze, E. G. E., Bhatt, M., van Meer, P. J. K., Havinga, I. K., Gispen-de Wied, C. C. & Mol, P. G. M., 11-mrt-2021, In: Frontiers in Medicine. 12 blz., 643028.Onderzoeksoutput › Academic › peer review
Open AccessBestand
Activiteiten
-
Value and potential of patient registries: Patient Registry Initiative & European Cystic Fibrosis Society Patient Registry
Peter G. M. Mol (Invited speaker)
9-feb-2018Activiteit: Academic presentation › Academic
-
Registries for post-licensing evidence generation.
Peter G. M. Mol (Invited speaker)
17-apr-2018 → 19-apr-2018Activiteit: Academic presentation › Academic
-
Real World Data to support regulatory decision-making’ together with FA Sayed-Tabatabaei
Peter G. M. Mol (Keynote speaker)
16-apr-2018Activiteit: Academic presentation › Academic
-
Versnelde beschikbaarheid van geneesmiddelen door ketensamenwerking. Een Europees CBG perspectief.
Peter G. M. Mol (Invited speaker)
13-jun-2018Activiteit: Academic presentation › Academic
-
Regulatory knowledge transfer: experience from SCOPE and WEB-RADR
Peter G. M. Mol (Invited speaker)
apr-2018Activiteit: Professional or public presentation › Professional
Prijzen
-
Among the most popular publications in Drug Safety in 2017
de Vries, Sieta (Recipient) & Mol, Peter (Recipient), 2017
Prijs: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prijs: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prijs: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-apr-2019
Prijs: Other distinction › Academic